🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 31/08/1981 | 0,0172 USD |
| 01/06/1981 | 0,0172 USD |
| 02/03/1981 | 0,0172 USD |
| 02/12/1980 | 0,0172 USD |
| 29/08/1980 | 0,0152 USD |
| 02/06/1980 | 0,0152 USD |
| 28/02/1980 | 0,0152 USD |
| 03/12/1979 | 0,0152 USD |
| 31/08/1979 | 0,0126 USD |
| 25/05/1979 | 0,0126 USD |
| 01/03/1979 | 0,0126 USD |
| 04/12/1978 | 0,0126 USD |
| 28/08/1978 | 0,0113 USD |
| 26/05/1978 | 0,0113 USD |
| 02/03/1978 | 0,0113 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/04/2016 | 54,13 | 54,75 | 53,65 | 54,26 | +0,62% | 2,04% | 8.011.122 |
| 18/04/2016 | 53,57 | 54,23 | 53,36 | 53,92 | +0,66% | 1,62% | 8.168.322 |
| 15/04/2016 | 53,94 | 53,96 | 53,32 | 53,57 | -0,55% | 1,19% | 8.839.251 |
| 14/04/2016 | 53,45 | 54,01 | 53,38 | 53,86 | +0,88% | 1,18% | 8.757.822 |
| 13/04/2016 | 52,92 | 53,43 | 52,74 | 53,40 | +1,12% | 1,30% | 8.849.836 |
| 12/04/2016 | 52,45 | 53,20 | 52,42 | 52,81 | +0,53% | 1,47% | 6.221.976 |
| 11/04/2016 | 52,83 | 53,19 | 52,46 | 52,53 | -0,56% | 1,37% | 7.404.749 |
| 08/04/2016 | 53,20 | 53,35 | 52,58 | 52,82 | -0,11% | 1,45% | 7.322.795 |
| 07/04/2016 | 52,81 | 53,23 | 52,53 | 52,88 | -0,38% | 1,32% | 11.042.566 |
| 06/04/2016 | 51,86 | 53,23 | 51,77 | 53,08 | +2,56% | 2,82% | 13.079.459 |
| 05/04/2016 | 51,61 | 52,21 | 51,52 | 51,76 | -0,29% | 1,35% | 9.432.838 |
| 04/04/2016 | 51,44 | 52,13 | 51,29 | 51,91 | +1,30% | 1,63% | 10.741.581 |
| 01/04/2016 | 50,10 | 51,33 | 50,04 | 51,24 | +1,49% | 2,57% | 9.099.889 |
| 31/03/2016 | 50,65 | 51,03 | 50,34 | 50,49 | -0,58% | 1,36% | 8.735.080 |
| 30/03/2016 | 51,03 | 51,10 | 50,68 | 50,78 | -0,19% | 0,82% | 6.711.287 |
| 29/03/2016 | 50,49 | 50,96 | 50,16 | 50,88 | +0,93% | 1,59% | 7.730.782 |
| 28/03/2016 | 50,69 | 50,85 | 50,24 | 50,41 | -0,45% | 1,20% | 6.337.046 |
| 24/03/2016 | 50,37 | 50,91 | 50,18 | 50,64 | -0,02% | 1,44% | 7.929.378 |
| 23/03/2016 | 51,15 | 51,15 | 50,43 | 50,65 | +0,09% | 1,40% | 10.424.980 |
| 22/03/2016 | 50,17 | 51,01 | 50,14 | 50,60 | +0,44% | 1,73% | 9.748.810 |
| 21/03/2016 | 49,93 | 50,41 | 49,71 | 50,38 | +1,05% | 1,40% | 8.014.161 |
| 18/03/2016 | 49,37 | 50,02 | 49,23 | 49,86 | +1,40% | 1,60% | 15.116.666 |
| 17/03/2016 | 49,55 | 49,59 | 48,98 | 49,17 | -0,79% | 1,23% | 10.038.163 |
| 16/03/2016 | 49,91 | 49,91 | 49,20 | 49,56 | -0,92% | 1,43% | 10.460.402 |
| 15/03/2016 | 50,08 | 50,23 | 49,57 | 50,02 | -1,24% | 1,31% | 9.495.614 |
| 14/03/2016 | 50,72 | 50,88 | 50,42 | 50,65 | -0,23% | 0,90% | 6.846.479 |
| 11/03/2016 | 50,59 | 51,01 | 50,36 | 50,76 | +0,30% | 1,28% | 16.277.955 |
| 10/03/2016 | 50,28 | 50,80 | 50,03 | 50,61 | +1,30% | 1,54% | 12.856.340 |
| 09/03/2016 | 50,17 | 50,47 | 49,71 | 49,96 | -0,17% | 1,50% | 9.589.829 |
| 08/03/2016 | 49,96 | 50,51 | 49,90 | 50,05 | -0,36% | 1,22% | 8.665.912 |